LATCHMIE RAMSAYWACK: Open Payments
NPI 1952983090 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 64 payments from 12 companies in 2025. Trend: 2023 $663 · 2024 $1,546 · 2025 $2,024
Food & beverage: $2,024
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $1,062 |
| GlaxoSmithKline, LLC. | 20 | $541 |
| Viatris Specialty LLC | 5 | $147 |
| Verona Pharma, Inc. | 3 | $51 |
| ANI Pharmaceuticals, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Electromed, Inc. | 3 | $34 |
| Amgen Inc. | 2 | $33 |
| United Therapeutics Corporation | 2 | $32 |
| CVRx, Inc. | 1 | $21 |
Products named: FASENRA, NUCALA, BREZTRI, YUPELRI, TEZSPIRE, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
